Vistin Pharma ASA (OSL:VISTN)
Norway · Delayed Price · Currency is NOK 19.00
-0.05 (-0.26%)
At close: Sep 11, 2026
Vistin Pharma ASA Market Cap
Vistin Pharma ASA has a market cap or net worth of 842.55 million as of September 11, 2026. Its market cap has decreased by -17.75% in one year.
Market Cap
842.55M
Enterprise Value
850.98M
Revenue
432.00M
Ranking
n/a
PE Ratio
12.00
Stock Price
19.00
ChartMarket Cap Chart
Since June 10, 2015, Vistin Pharma ASA's market cap has increased from 322.34M to 842.55M, an increase of 161.39%. That is a compound annual growth rate of 8.91%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 842.55M | -8.65% |
| Dec 30, 2025 | 922.37M | -12.24% |
| Dec 30, 2024 | 1.05B | 1.72% |
| Dec 29, 2023 | 1.03B | 47.47% |
| Dec 30, 2022 | 700.64M | -18.47% |
| Dec 30, 2021 | 859.40M | 11.06% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 4.50B |
| Circio Holding ASA | 3.55B |
| Thor Medical ASA | 2.01B |
| Nordhealth AS | 1.97B |
| ArcticZymes Technologies ASA | 1.10B |
| Omda AS | 881.83M |
| INIFY Laboratories AB | 644.85M |
| Lytix Biopharma ASA | 630.58M |